化基因及其与子宫内膜异位症妇女症状严重性的关联
Anton Sommar1,2, Pinar Yalcin Bahat3, Ipek Yildiz Özaydin4
1Department of Clinical Sciences, Obstetrics and Gynecology, Umeå University, Umeå, Sweden.
American journal of reproductive immunology (New York, N.Y. : 1989)
|September 4, 2025
概括
像CCL2,CXCL8和CXCL1这样的化学物质与子宫内膜异位症疼痛有关. 这些化学因子,特别是CXCL1的较高水平与子宫内膜异位症患者的疼痛严重程度增加相关.
科学领域:
- 生殖免疫学
- 疼痛研究
- 分子生物学
背景情况:
- 子宫内膜异位症与慢性盆腔疼痛有关.
- 化学因子 (CCL2,CXCL8,CXCL1) 参与疼痛信号和炎症.
- 在子宫内膜异位症相关的疼痛严重性中,特定化学因子的作用需要进一步阐明.
研究的目的:
- 在患有子宫内膜异位症的妇女中,研究血清和子宫内膜异位素水平 (CCL2,CXCL8,CXCL1) 与疼痛严重程度之间的关联.
- 探索子宫内膜异位症患者和健康对照患者之间化学因子特征的潜在差异.
- 确定可能作为子宫内膜异位症疼痛生物标志物的特定化学因子.
主要方法:
- 涉及子宫内膜异位症妇女 (有/没有激素治疗) 和健康对照者的横截面研究.
- 在分泌阶段取血清样本和子宫内膜活检.
- 使用子宫内膜异位症健康状况30 (EHP-30) 疼痛域和视觉模拟尺度 (VAS) 的疼痛评估.
主要成果:
- 在子宫内膜异位症患者中较低的血清CCL2和CXCL1,以及子宫内膜异位症CXCL8.
- 血清CCL2,CXCL8和CXCL1的增加与更高的EHP-30疼痛得分相关.
- 增加的子宫内膜CXCL8和CXCL1与更高的VAS疼痛得分相关.
- 无论使用何种激素治疗,CXCL1与疼痛严重程度存在一致的关联.
结论:
- 化学物质,特别是CXCL1,与子宫内膜异位症患者的疼痛严重程度增加和生活质量降低有关.
- 血清和子宫内膜CXCL1水平可能是子宫内膜异位症疼痛强度的潜在指标.
- 不能确定因果关系,需要进一步研究.
相关概念视频
01:24Disorders of the Female Reproductive System
486
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
486
02:07Oogenesis
64.3K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
64.3K
01:28Menopause
248
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
248
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
259
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
259